Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents-Reference-Cited by-同舟云学术

Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents

Published:2022-06-22 Issue:8 Volume:17 Page:839-848
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Jailani Ameera B. A.¹^ORCID,Bigos Kamilla J. A.¹^ORCID,Avgoustou Paris¹^ORCID,Egan Joseph L.²^ORCID,Hathway Robert A.²^ORCID,Skerry Timothy M.¹^ORCID,Richards Gareth O.¹^ORCID

Affiliation:

1. Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK

2. Department of Chemistry, University of Sheffield, Sheffield, UK

Funder

University of Sheffield

EPSRC

MRC DiMeN Doctoral Training Partnership Studentship

Prostate Cancer UK

Wellcome Trust

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2090541

Reference105 articles.

1. Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential

2. The pharmacology of Adrenomedullin 2/Intermedin

3. Production and Secretion of Adrenomedullin from Vascular Smooth-Muscle Cells: Augmented Production by Tumor Necrosis Factor-α

4. Plasma Adrenomedullin Concentrations in Essential Hypertension

5. Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Adrenomedullin as a Predictive Marker of the Risk of Death and Adverse Clinical Events: A Review of the Literature;Journal of Clinical Medicine;2024-08-16

2. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families;Cancers;2023-03-09

3. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment;Frontiers in Molecular Biosciences;2023-02-07

4. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins;Pharmacological Reviews;2022-12-08